Related Experiment Video

Updated: Jun 23, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies

Leszek Bryniarski1, Agnieszka Pelc-Nowicka, Michał Zabojszcz

  • 11st Department of Cardiology and Hypertension, Institute of Cardiology, Jagiellonian University, Medical College, Krakow, Poland. l_bryniarski@poczta.fm

Cardiology Journal
|April 24, 2009
PubMed

Insights

Dual antiplatelet therapy is standard for acute coronary syndromes. However, its use with antithrombotic therapy requires further trials, especially concerning bleeding risks in specific patient groups.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Pharmacology

Background:

  • Dual antiplatelet therapy (DAPT) is recommended for acute coronary syndromes (ACS).
  • Antiplatelet agents are central to interventional cardiology pharmacotherapy.
  • A gap exists in evidence for DAPT combined with long-term antithrombotic therapy.

Purpose of the Study:

  • To review trials and analyses of DAPT combined with antithrombotic therapy.
  • To focus on the hemorrhagic risks associated with combined therapies.
  • To discuss current European Society of Cardiology and American College of Cardiology/American Heart Association guidelines.

Main Methods:

  • Review of existing randomized trials and analyses.
  • Discussion of specific patient populations requiring antithrombotic treatment.
  • Examination of bleeding event data in combined therapy scenarios.

Main Results:

  • Current guidelines recommend DAPT for ACS, irrespective of treatment modality.
  • Evidence is limited for optimal DAPT strategies in patients needing concurrent antithrombotic therapy.
  • Combined therapy increases the risk of hemorrhagic events, necessitating careful patient selection and monitoring.

Conclusions:

  • Further randomized trials are essential to guide DAPT use in patients requiring long-term antithrombotic treatment.
  • Balancing antithrombotic efficacy with bleeding risk is crucial in complex cardiovascular cases.
  • Updated guidelines address these complexities, emphasizing individualized treatment approaches.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...